Redirecting to http://dergipark.org.tr/_fragment?_hash=0lhuXiyGy4NR0VN7HOlxZRFNPk1Iu3UqcL2eDfSh2f8&_path=id%3D1350983%26_format%3Dhtml%26_locale%3Den%26_controller%3DApp%255CController%255CSite%255CArticleController%253A%253AesiArticleStats.
Conference Paper
BibTex RIS Cite

DNA Profiling of ING1 Gene in Triple Negative Breast Cancer

Year 2023, Volume: 22, 280 - 284, 01.09.2023

Alaa Anwer Ezzet Isik Didem Karagoz , Sibel Cangı Tulay Kus

https://doi.org/10.55549/epstem.1350983

Abstract

Breast cancer is among the most common cancers and the second in death caused from cancers in women. Triple negative breast cancer (TNBC) is a subgroup which not expressed estrogen (ER), progesterone (PR) and HER2 receptors in breast cancer. It has 15% rate of all breast cancer and has been more aggressive and has poor prognosis. For this reason, early diagnosis has a key role because of TNBC’s high relapse. Investigation of DNA methylation pattern in TNBC likewise all types of breast cancer has become an important prognostic vehicle besides assessment of gene expression profile in diagnosis cancer subtypes. DNA methylation pattern of tumor suppressor genes which is one of the epigenetic modifications has highly importance. In this study, we aimed to investigate the relationship DNA methylation pattern of ING1 (inhibitor of growth family member 1), a tumor suppressor gene and TNBC. For this purpose, we searched the methylation pattern of ING1 and breast cancer patients especially TNBC. As a result, we discussed and tried to clarified the relationship between epigenetic modifications of ING1 gene and TNBC.

Keywords

Breast cancer Triple negative breast cancer Epigenetic factors DNA methylation ING1 gene

References

  • Bányai, L., Trexler, M., Kerekes, K., Csuka, O., & Patthy, L. (2021). Use of signals of positive and negative selection to distinguish cancer genes and passenger genes. Elife, 10. e59629. Blondel, A., Benberghout, A., Pedeux, R., & Ricordel, C. (2019). Exploiting ING2 epigenetic modulation as a therapeutic opportunity for non-small cell lung cancer. Cancers, 11(10), 1601; https://doi.org/10.3390/cancers11101601

Year 2023, Volume: 22, 280 - 284, 01.09.2023

Alaa Anwer Ezzet Isik Didem Karagoz , Sibel Cangı Tulay Kus

https://doi.org/10.55549/epstem.1350983

Abstract

References

  • Bányai, L., Trexler, M., Kerekes, K., Csuka, O., & Patthy, L. (2021). Use of signals of positive and negative selection to distinguish cancer genes and passenger genes. Elife, 10. e59629. Blondel, A., Benberghout, A., Pedeux, R., & Ricordel, C. (2019). Exploiting ING2 epigenetic modulation as a therapeutic opportunity for non-small cell lung cancer. Cancers, 11(10), 1601; https://doi.org/10.3390/cancers11101601
There are 1 citations in total.

Details

Primary Language English
Subjects Electrochemical Technologies
Journal Section Articles
Authors

Alaa Anwer Ezzet

Isik Didem Karagoz

Sibel Cangı

Tulay Kus

Early Pub Date August 27, 2023
Publication Date September 1, 2023
Published in Issue Year 2023 Volume: 22

Cite

APA Ezzet, A. A., Karagoz, I. D., Cangı, S., Kus, T. (2023). DNA Profiling of ING1 Gene in Triple Negative Breast Cancer. The Eurasia Proceedings of Science Technology Engineering and Mathematics, 22, 280-284. https://doi.org/10.55549/epstem.1350983
Creative Commons License